What Approaches to Thwart Bacterial Efflux Pumps-Mediated Resistance?

Area of Science:

• Microbiology
• Pharmacology
• Biochemistry

Background:

• Antimicrobial resistance (AMR) poses a significant global health challenge, leading to increased infections and mortality.
• Bacteria employ various resistance mechanisms, with over-expression of efflux pumps (EPs) being a primary strategy driving multidrug resistance (MDR).
• Conventional antibiotics are becoming less effective against resistant bacterial strains.

Purpose of the Study:

• To review the role of efflux pumps (EPs) in the development of multidrug resistance (MDR).
• To explore current and emerging strategies, termed antibiotic resistance breakers (ARBs), to counteract EP-mediated resistance.
• To identify challenges associated with the development of these counter-strategies.

Main Methods:

• Literature review focusing on bacterial efflux pumps and resistance mechanisms.
• Analysis of various classes of antibiotic resistance breakers (ARBs), including efflux pump inhibitors (EPIs).
• Exploration of natural product-based solutions and alternative therapies such as nanoparticle carriers, biologics, and phage therapy.

Main Results:

• Efflux pumps (EPs) are critical in conferring multidrug resistance (MDR) by expelling antibiotics from bacterial cells.
• Efflux pump inhibitors (EPIs) are a key class of ARBs aimed at restoring antibiotic susceptibility.
• Natural compounds from plant extracts show promise as safer alternatives to synthetic EPIs due to lower toxicity.

Conclusions:

• Addressing AMR requires a dual approach of prevention and treatment, with a focus on overcoming bacterial resistance mechanisms.
• Developing effective efflux pump inhibitors (EPIs) and exploring alternative therapies are crucial for combating MDR.
• Overcoming challenges in the development and application of these strategies is essential for future antimicrobial therapies.